Helix Holdings LLC is of MoonLake Immunotherapeutics. Currently has a direct ownership of 3.22 Million shares of MLTX, which is worth approximately $169 Million. The most recent transaction as insider was on Apr 05, 2022, when has been sold 2,785,000 shares (Class A Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.22M
0% 3M change
0% 12M change
Total Value Held $169 Million

Helix Holdings LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 05 2022
BUY
Conversion of derivative security
-
2,785,000 Added 46.42%
3,215,000 Class A Ordinary Shares
Oct 22 2020
BUY
Open market or private purchase
$4,300,000 $10.0 p/Share
430,000 Added 50.0%
430,000 Class A Ordinary Shares
HHL

Helix Holdings LLC

Boston, MA

Track Institutional and Insider Activities on MLTX

Follow MoonLake Immunotherapeutics and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MLTX shares.

Notify only if

Insider Trading

Get notified when an Moon Lake Immunotherapeutics insider buys or sells MLTX shares.

Notify only if

News

Receive news related to MoonLake Immunotherapeutics

Track Activities on MLTX